Literature DB >> 10828993

Inhibition of the human sodium/bile acid cotransporters by side-specific methanethiosulfonate sulfhydryl reagents: substrate-controlled accessibility of site of inactivation.

S Hallén1, J Fryklund, G Sachs.   

Abstract

Mammalian sodium/bile acid cotransporters (SBATs) constitute a subgroup of the sodium cotransporter superfamily and function in the enterohepatic circulation of bile acids. They are glycoproteins with an exoplasmic N-terminus, seven or nine transmembrane segments, and a cytoplasmic C-terminus. They exhibit no significant homology with other members of the sodium cotransporter family and there is limited structure/function information available for the SBATs. Membrane-impermeant methanethiosulfonates (MTS) inhibited bile acid transport by alkylation of cysteine 270 (apical SBAT)/266 (basolateral SBAT) that is fully conserved among the sodium/bile acid cotransporters. The accessibility of this residue to MTS reagent is regulated by the natural substrates, sodium and bile acid. In experiments with the apical SBAT, sodium alone increases the reactivity with the thiol reagents as compared to sodium-free medium. In contrast, bile acids protect the SBATs from inactivation, although only in the presence of sodium. The inhibition and protection data suggest that cysteine 270/266 lies in a sodium-sensitive region of the SBATs that is implicated in bile acid transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828993     DOI: 10.1021/bi000577t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Specific bile acids inhibit hepatic fatty acid uptake in mice.

Authors:  Biao Nie; Hyo Min Park; Melissa Kazantzis; Min Lin; Amy Henkin; Stephanie Ng; Sujin Song; Yuli Chen; Heather Tran; Robin Lai; Chris Her; Jacquelyn J Maher; Barry M Forman; Andreas Stahl
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

2.  Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains.

Authors:  Antara Banerjee; Peter W Swaan
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

3.  Cysteine 96 of Ntcp is responsible for NO-mediated inhibition of taurocholate uptake.

Authors:  Umadevi Ramasamy; M Sawkat Anwer; Christopher M Schonhoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

Review 4.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

Review 5.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 6.  The sodium bile salt cotransport family SLC10.

Authors:  Bruno Hagenbuch; Paul Dawson
Journal:  Pflugers Arch       Date:  2003-07-08       Impact factor: 3.657

Review 7.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

Review 8.  The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.

Authors:  J Geyer; T Wilke; E Petzinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-16       Impact factor: 3.000

Review 9.  Exploitation of bile acid transport systems in prodrug design.

Authors:  Elina Sievänen
Journal:  Molecules       Date:  2007-08-16       Impact factor: 4.411

10.  Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporter.

Authors:  Naissan Hussainzada; Akash Khandewal; Peter W Swaan
Journal:  Mol Pharmacol       Date:  2007-10-30       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.